Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology.

Saved in:
Bibliographic Details
Title: Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology.
Authors: Schauer SP; Department of Translational Medicine, OMNI, Genentech Inc., South San Francisco, California, USA., Toth B; Department of Data and Statistical Sciences, Immunology, Infectious Diseases, and Ophthalmology, Genentech Inc., South San Francisco, California, USA., Lee J; Department of Translational Medicine, OMNI, Genentech Inc., South San Francisco, California, USA., Honigberg LA; Department of Translational Medicine, OMNI, Genentech Inc., South San Francisco, California, USA., Ramakrishnan V; Department of Clinical Pharmacology, Modeling and Simulation, Development Sciences, Genentech Inc., South San Francisco, California, USA., Jiang J; Department of Translational Medicine, OMNI, Genentech Inc., South San Francisco, California, USA., Kollmorgen G; Roche Diagnostics, GmbH, Penzberg, Germany., Bayfield A; Roche Diagnostics, GmbH, Penzberg, Germany., Wild N; Roche Diagnostics, GmbH, Penzberg, Germany., Hoffman J; Department of Translational Medicine, Operations Diagnostics Technology Innovation, Genentech Inc., South San Francisco, California, USA., Ceniceros R; Department of Early Clinical Development, Clinical Operations, Genentech Inc., South San Francisco, California, USA., Dolton M; Department of Clinical Pharmacology, Modeling and Simulation, Development Sciences, Genentech Inc., South San Francisco, California, USA., Bohórquez SMS; Department of Early Clinical Development, Clinical Imaging Group, Genentech Inc., South San Francisco, California, USA., Hoogenraad CC; Department of Neuroscience, Genentech Inc., South San Francisco, California, USA., Wildsmith KR; Department of Translational Medicine, OMNI, Genentech Inc., South San Francisco, California, USA., Teng E; Department of Early Clinical Development, OMNI, Genentech Inc., South San Francisco, California, USA., Monteiro C; Department of Early Clinical Development, OMNI, Genentech Inc., South San Francisco, California, USA., Anania V; Department of Translational Medicine, OMNI, Genentech Inc., South San Francisco, California, USA., Yeh FL; Department of Translational Medicine, OMNI, Genentech Inc., South San Francisco, California, USA.
Source: Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2024 Dec; Vol. 20 (12), pp. 8855-8866. Date of Electronic Publication: 2024 Nov 08.
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: John Wiley & Sons, Ltd Country of Publication: United States NLM ID: 101231978 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-5279 (Electronic) Linking ISSN: 15525260 NLM ISO Abbreviation: Alzheimers Dement Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39513754
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Schauer+SP%22">Schauer SP</searchLink>; Department of Translational Medicine, OMNI, Genentech Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Toth+B%22">Toth B</searchLink>; Department of Data and Statistical Sciences, Immunology, Infectious Diseases, and Ophthalmology, Genentech Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Lee+J%22">Lee J</searchLink>; Department of Translational Medicine, OMNI, Genentech Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Honigberg+LA%22">Honigberg LA</searchLink>; Department of Translational Medicine, OMNI, Genentech Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Ramakrishnan+V%22">Ramakrishnan V</searchLink>; Department of Clinical Pharmacology, Modeling and Simulation, Development Sciences, Genentech Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Jiang+J%22">Jiang J</searchLink>; Department of Translational Medicine, OMNI, Genentech Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Kollmorgen+G%22">Kollmorgen G</searchLink>; Roche Diagnostics, GmbH, Penzberg, Germany.<br /><searchLink fieldCode="AU" term="%22Bayfield+A%22">Bayfield A</searchLink>; Roche Diagnostics, GmbH, Penzberg, Germany.<br /><searchLink fieldCode="AU" term="%22Wild+N%22">Wild N</searchLink>; Roche Diagnostics, GmbH, Penzberg, Germany.<br /><searchLink fieldCode="AU" term="%22Hoffman+J%22">Hoffman J</searchLink>; Department of Translational Medicine, Operations Diagnostics Technology Innovation, Genentech Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Ceniceros+R%22">Ceniceros R</searchLink>; Department of Early Clinical Development, Clinical Operations, Genentech Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Dolton+M%22">Dolton M</searchLink>; Department of Clinical Pharmacology, Modeling and Simulation, Development Sciences, Genentech Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Bohórquez+SMS%22">Bohórquez SMS</searchLink>; Department of Early Clinical Development, Clinical Imaging Group, Genentech Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Hoogenraad+CC%22">Hoogenraad CC</searchLink>; Department of Neuroscience, Genentech Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Wildsmith+KR%22">Wildsmith KR</searchLink>; Department of Translational Medicine, OMNI, Genentech Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Teng+E%22">Teng E</searchLink>; Department of Early Clinical Development, OMNI, Genentech Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Monteiro+C%22">Monteiro C</searchLink>; Department of Early Clinical Development, OMNI, Genentech Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Anania+V%22">Anania V</searchLink>; Department of Translational Medicine, OMNI, Genentech Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Yeh+FL%22">Yeh FL</searchLink>; Department of Translational Medicine, OMNI, Genentech Inc., South San Francisco, California, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101231978%22">Alzheimer's & dementia : the journal of the Alzheimer's Association</searchLink> [Alzheimers Dement] 2024 Dec; Vol. 20 (12), pp. 8855-8866. <i>Date of Electronic Publication: </i>2024 Nov 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Ltd%22">John Wiley & Sons, Ltd </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101231978 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1552-5279 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215525260%22">15525260 </searchLink><i>NLM ISO Abbreviation: </i>Alzheimers Dement <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39513754
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/alz.14346
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 8855
    Titles:
      – TitleFull: Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schauer SP
      – PersonEntity:
          Name:
            NameFull: Toth B
      – PersonEntity:
          Name:
            NameFull: Lee J
      – PersonEntity:
          Name:
            NameFull: Honigberg LA
      – PersonEntity:
          Name:
            NameFull: Ramakrishnan V
      – PersonEntity:
          Name:
            NameFull: Jiang J
      – PersonEntity:
          Name:
            NameFull: Kollmorgen G
      – PersonEntity:
          Name:
            NameFull: Bayfield A
      – PersonEntity:
          Name:
            NameFull: Wild N
      – PersonEntity:
          Name:
            NameFull: Hoffman J
      – PersonEntity:
          Name:
            NameFull: Ceniceros R
      – PersonEntity:
          Name:
            NameFull: Dolton M
      – PersonEntity:
          Name:
            NameFull: Bohórquez SMS
      – PersonEntity:
          Name:
            NameFull: Hoogenraad CC
      – PersonEntity:
          Name:
            NameFull: Wildsmith KR
      – PersonEntity:
          Name:
            NameFull: Teng E
      – PersonEntity:
          Name:
            NameFull: Monteiro C
      – PersonEntity:
          Name:
            NameFull: Anania V
      – PersonEntity:
          Name:
            NameFull: Yeh FL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2024 Dec
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1552-5279
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Alzheimer's & dementia : the journal of the Alzheimer's Association
              Type: main
ResultId 1